Well Lead Medical Co., Ltd. (603309.SS)
CNY 12.51
(0.89%)
CNY 12.51
(0.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 192.48 Million CNY | 15.56% |
| 2022 | 166.57 Million CNY | 57.0% |
| 2021 | 106.09 Million CNY | -30.71% |
| 2020 | 153.11 Million CNY | 26.39% |
| 2019 | 121.14 Million CNY | 85.23% |
| 2018 | 65.4 Million CNY | 1.31% |
| 2017 | 64.55 Million CNY | -18.54% |
| 2016 | 79.24 Million CNY | -13.22% |
| 2015 | 91.32 Million CNY | 34.66% |
| 2014 | 67.81 Million CNY | 6.66% |
| 2013 | 63.58 Million CNY | 14.34% |
| 2012 | 55.6 Million CNY | 16.03% |
| 2011 | 47.92 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 60.67 Million CNY | 8.74% |
| 2024 Q1 | 50.25 Million CNY | 3.48% |
| 2024 Q2 | 55.79 Million CNY | 11.03% |
| 2023 Q3 | 51.83 Million CNY | 29.65% |
| 2023 Q2 | 39.98 Million CNY | -23.25% |
| 2023 FY | 192.48 Million CNY | 15.56% |
| 2023 Q1 | 52.09 Million CNY | 79.23% |
| 2023 Q4 | 48.56 Million CNY | -6.31% |
| 2022 FY | 166.57 Million CNY | 57.0% |
| 2022 Q3 | 55.18 Million CNY | 26.28% |
| 2022 Q2 | 43.7 Million CNY | 13.18% |
| 2022 Q1 | 38.61 Million CNY | 58.68% |
| 2022 Q4 | 29.06 Million CNY | -47.33% |
| 2021 Q4 | 24.33 Million CNY | -30.91% |
| 2021 Q1 | 22.7 Million CNY | 67.54% |
| 2021 FY | 106.09 Million CNY | -30.71% |
| 2021 Q2 | 23.83 Million CNY | 5.02% |
| 2021 Q3 | 35.22 Million CNY | 47.74% |
| 2020 Q4 | 13.54 Million CNY | -68.1% |
| 2020 Q2 | 89.18 Million CNY | 1029.89% |
| 2020 Q1 | 7.89 Million CNY | -53.18% |
| 2020 FY | 153.11 Million CNY | 26.39% |
| 2020 Q3 | 42.47 Million CNY | -52.37% |
| 2019 Q2 | 51.91 Million CNY | 163.75% |
| 2019 FY | 121.14 Million CNY | 85.23% |
| 2019 Q1 | 19.68 Million CNY | -15.0% |
| 2019 Q4 | 16.86 Million CNY | -48.41% |
| 2019 Q3 | 32.68 Million CNY | -37.05% |
| 2018 Q2 | 19.19 Million CNY | 211.6% |
| 2018 Q3 | 16.88 Million CNY | -12.03% |
| 2018 Q4 | 23.15 Million CNY | 37.13% |
| 2018 FY | 65.4 Million CNY | 1.31% |
| 2018 Q1 | 6.16 Million CNY | -49.29% |
| 2017 FY | 64.55 Million CNY | -18.54% |
| 2017 Q4 | 12.15 Million CNY | -3.96% |
| 2017 Q3 | 12.65 Million CNY | -49.2% |
| 2017 Q1 | 14.85 Million CNY | -21.18% |
| 2017 Q2 | 24.9 Million CNY | 67.66% |
| 2016 Q1 | 14.13 Million CNY | -33.73% |
| 2016 Q4 | 18.84 Million CNY | -24.83% |
| 2016 FY | 79.24 Million CNY | -13.22% |
| 2016 Q3 | 25.07 Million CNY | 18.25% |
| 2016 Q2 | 21.2 Million CNY | 50.03% |
| 2015 Q3 | 26.9 Million CNY | -8.93% |
| 2015 Q1 | 13.55 Million CNY | -1.94% |
| 2015 FY | 91.32 Million CNY | 34.66% |
| 2015 Q4 | 21.32 Million CNY | -20.75% |
| 2015 Q2 | 29.54 Million CNY | 117.97% |
| 2014 Q2 | 22.18 Million CNY | 82.46% |
| 2014 Q4 | 13.82 Million CNY | -29.69% |
| 2014 Q1 | 12.15 Million CNY | 0.0% |
| 2014 FY | 67.81 Million CNY | 6.66% |
| 2014 Q3 | 19.65 Million CNY | -11.38% |
| 2013 FY | 63.58 Million CNY | 14.34% |
| 2012 FY | 55.6 Million CNY | 16.03% |
| 2011 FY | 47.92 Million CNY | 0.0% |